Economic analysis falls short when it comes to medicines’ value

26 February 2019 - For the past two decades, a plethora of organisations identified by various innocuous acronyms (e.g., NICE) ...

Read more →

New drug landscape dominated by high cost medicines

19 February 2019 - The Patented Medicine Prices Review Board, through the National Prescription Drug Utilization Information System research initiative, ...

Read more →

Quebec appeals court orders province to restore full coverage of rheumatoid-arthritis drug Remicade

13 February 2019 - Quebec’s highest court has ordered the provincial government to restore full public coverage of Remicade, an ...

Read more →

FDA finalises new policy to encourage widespread innovation and development of new buprenorphine treatments for opioid use disorder

6 February 2019 - Today, the U.S. FDA issued a final guidance, “Opioid Use Disorder: Developing Buprenorphine Depot Products for Treatment,” ...

Read more →

Ottawa’s push for lower drug costs may hurt patients, stunt innovation

24 January 2019 - The federal government’s plan to lower prescription drug prices could impede access and thus limit the ...

Read more →

Toward an effective innovation agenda

23 January 2019 - Digital technologies have transformed the U.S. and global economies, offering tremendous benefits to consumers and financial success ...

Read more →

New agreement on branded drugs for the NHS

18 January 2019 - The new Voluntary Scheme for Branded Medicines Pricing and Access began on 1 January and was ...

Read more →

Would drug price controls kill innovation?

14 January 2019 - Affordability doesn’t need to come at the expense of innovation. ...

Read more →

Regeneron CEO: ‘we need a carrot-and-stick system’ to balance pricing and innovation

10 January 2019 - Amid ongoing furore over prescription drug pricing, Regeneron Pharmaceuticals chief executive Len Schleifer has sometimes gleefully ...

Read more →

2018: a year of innovation, efficiency, and new advances in drug therapy for the American public

7 January 2019 - The beginning of a new year is a good opportunity to look back over the past ...

Read more →

Statement from FDA Commissioner and Director of the Center for Devices and Radiological Health on new steps to promote innovations in medical devices that help advance patient safety

18 December 2018 - Spurring innovation of medical products so that patients can have access to safe, effective treatments that ...

Read more →

Bernie Sanders' drug price controls would stifle medical innovation

11 December 2018 - Senator Bernie Sanders and Representative Ro Khanna recently proposed bills that would impose price controls on ...

Read more →

Underuse of innovative medicines in Germany: A justification for government intervention?

6 December 2018 - The German market for innovative medicines is characterised by simultaneous underuse and overuse.  ...

Read more →

Why regulators must move with the science if we’re to get innovative new treatments to patients more quickly

5 December 2018 - Professor Paul Workman, discusses the findings of the ICR's new drug access report, which asks how we ...

Read more →

Flexibility on cancer drugs approval will foster innovation

4 December 2018 - Between 2000 and 2016, no new drugs were approved for cancers of the brain, and there were ...

Read more →